Drug responseDRUG → SHRNACell lineZoledronic acid, Zometa, Reclast
Across CCLE and GDSC cell-line panels, response to Zoledronate is significantly associated with the shRNA dependency of multiple gene dependencies, with PANCREAS cell lines showing a particularly strong set of associations.
The most reproducible Zoledronate response-associated gene dependencies across cancer lineages are AXIN1, ATP6V0C, and MUC1, each associated with drug response in up to 8 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, Zoledronate response versus AXIN1 shRNA dependency in PANCREAS (Pearson r = 0.63).
Shrna dependency biomarkers of Zoledronate response
Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.